Bio-Techne (TECH) Raw Materials (2010 - 2026)
Bio-Techne (TECH) recorded quarterly Raw Materials of $94.9 million in Q1 2026, down 1.36% quarter-over-quarter from $96.2 million in Q4 2025, and up 13.71% on a YoY basis from $83.5 million in Q1 2025.
Bio-Techne (TECH) Raw Materials (2010 - 2026) Analysis & Trends
Bio-Techne's Raw Materials history runs 17 years deep, the most recent figure standing at $94.9 million for Q1 2026.
- In Q1 2026, Raw Materials rose 13.71% year-over-year to $94.9 million; the TTM figure through Mar 2026 stood at $94.9 million (up 13.71% YoY), while the FY2025 annual figure was $89.1 million, up 12.22% from the prior year.
- Raw Materials was $94.9 million for Q1 2026 at Bio-Techne, down from $96.2 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $96.2 million in Q4 2025 to a low of $69.3 million in Q1 2022.
- Historically, Raw Materials has averaged $84.3 million across 5 years, with a median of $84.0 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Raw Materials soared 43.91% in 2022, then dropped 7.45% in 2024.
- A 5-year view of Raw Materials shows it stood at $84.8 million in 2022, then retreated by 1.78% to $83.2 million in 2023, then grew by 0.86% to $84.0 million in 2024, then climbed by 14.58% to $96.2 million in 2025, then dropped by 1.36% to $94.9 million in 2026.
- The last three Raw Materials figures came in at $94.9 million (Q1 2026), $96.2 million (Q4 2025), and $94.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.90 Mn |
| Dec 31, 2025 | 96.20 Mn |
| Sep 30, 2025 | 93.99 Mn |
| Jun 30, 2025 | 89.08 Mn |
| Mar 31, 2025 | 83.45 Mn |
| Dec 31, 2024 | 83.96 Mn |
| Sep 30, 2024 | 81.79 Mn |
| Jun 30, 2024 | 79.38 Mn |
| Mar 31, 2024 | 80.52 Mn |
| Dec 31, 2023 | 83.25 Mn |
| Sep 30, 2023 | 84.74 Mn |
| Jun 30, 2023 | 84.55 Mn |
| Mar 31, 2023 | 87.01 Mn |
| Dec 31, 2022 | 84.76 Mn |
| Sep 30, 2022 | 76.72 Mn |
| Jun 30, 2022 | 79.29 Mn |
| Mar 31, 2022 | 69.26 Mn |
| Dec 31, 2021 | 61.62 Mn |
| Sep 30, 2021 | 58.00 Mn |
| Jun 30, 2021 | 55.10 Mn |